• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

地锦草皂苷VI与生物活性因子BMP-2对成骨及抗破骨细胞生成的协同作用。

Synergy effects of Asperosaponin VI and bioactive factor BMP-2 on osteogenesis and anti-osteoclastogenesis.

作者信息

Chen Fangping, Liang Qing, Mao Lijie, Yin Yanrong, Zhang Lixin, Li Cuidi, Liu Changsheng

机构信息

Key Laboratory for Ultrafine Materials of Ministry of Education, School of Materials Science and Engineering, East China University of Science and Technology, Shanghai, 200237, PR China.

Engineering Research Center for Biomedical Materials of Ministry of Education, East China University of Science and Technology, Shanghai, 200237, PR China.

出版信息

Bioact Mater. 2021 Sep 10;10:335-344. doi: 10.1016/j.bioactmat.2021.09.001. eCollection 2022 Apr.

DOI:10.1016/j.bioactmat.2021.09.001
PMID:34901550
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8636809/
Abstract

Osteoporosis is a reduction in skeletal mass due to the decrease of osteogenic ability and the activation of the osteoclastic function. Inhibiting bone resorption and accelerating the new bone formation is a promising strategy to repair the bone defect of osteoporosis. In this study, we first systematically investigated the roles of Chinese medicine Asperosaponin VI (ASP VI) on osteogenic mineralization of BMSCs and osteoclastogenesis of BMMs, and then explored the synergistic effect of ASP VI and BS (BMP-2 immobilized in 2-N, 6-O-sulfated chitosan) on bone formation. The result showed that ASP VI with the concentration lower than 10 M contributed to the expression of osteogenic gene and inhibited osteoclastic genes RANKL of BMSCs. Simultaneously, ASP VI significantly reduced the differentiation of mononuclear osteoclasts in the process of osteoclast formation induced by M-CSF and RANKL. Furthermore, by stimulating the SMADs, TGF-β1, VEGFA, and OPG/RANKL signaling pathways, ASBS (ASP VI and BS) substantially enhanced osteogenesis, greatly promoted angiogenesis, and suppressed osteoclastogenesis. The findings provide a new perspective on osteoporosis care and prevention.

摘要

骨质疏松症是由于成骨能力下降和破骨细胞功能激活导致的骨量减少。抑制骨吸收并加速新骨形成是修复骨质疏松症骨缺损的一种有前景的策略。在本研究中,我们首先系统地研究了中药天冬皂苷 VI(ASP VI)对骨髓间充质干细胞(BMSCs)成骨矿化和骨髓巨噬细胞(BMMs)破骨细胞生成的作用,然后探讨了 ASP VI 与 BS(固定在 2-N,6-O-硫酸化壳聚糖上的骨形态发生蛋白-2)对骨形成的协同作用。结果表明,浓度低于 10 μM 的 ASP VI 有助于成骨基因的表达,并抑制 BMSCs 的破骨细胞基因 RANKL。同时,ASP VI 在 M-CSF 和 RANKL 诱导的破骨细胞形成过程中显著降低单核破骨细胞的分化。此外,通过刺激 SMADs、TGF-β1、VEGFA 和 OPG/RANKL 信号通路,ASBS(ASP VI 和 BS)显著增强成骨作用,极大地促进血管生成,并抑制破骨细胞生成。这些发现为骨质疏松症的护理和预防提供了新的视角。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6447/8636809/db5c16a5d7db/gr8.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6447/8636809/f39e742b2246/ga1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6447/8636809/eb2f35f0823e/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6447/8636809/05661b5f235d/gr2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6447/8636809/7deddc473140/gr3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6447/8636809/8fa6b6ed544a/gr4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6447/8636809/f9514981afe9/gr5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6447/8636809/b9381ca565cd/gr6.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6447/8636809/daf51092fe78/gr7.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6447/8636809/db5c16a5d7db/gr8.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6447/8636809/f39e742b2246/ga1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6447/8636809/eb2f35f0823e/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6447/8636809/05661b5f235d/gr2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6447/8636809/7deddc473140/gr3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6447/8636809/8fa6b6ed544a/gr4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6447/8636809/f9514981afe9/gr5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6447/8636809/b9381ca565cd/gr6.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6447/8636809/daf51092fe78/gr7.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6447/8636809/db5c16a5d7db/gr8.jpg

相似文献

1
Synergy effects of Asperosaponin VI and bioactive factor BMP-2 on osteogenesis and anti-osteoclastogenesis.地锦草皂苷VI与生物活性因子BMP-2对成骨及抗破骨细胞生成的协同作用。
Bioact Mater. 2021 Sep 10;10:335-344. doi: 10.1016/j.bioactmat.2021.09.001. eCollection 2022 Apr.
2
The synergistic effects of Sr and Si bioactive ions on osteogenesis, osteoclastogenesis and angiogenesis for osteoporotic bone regeneration.锶和硅生物活性离子对骨质疏松性骨再生的成骨、破骨和成血管的协同作用。
Acta Biomater. 2017 Oct 1;61:217-232. doi: 10.1016/j.actbio.2017.08.015. Epub 2017 Aug 12.
3
Asperosaponin VI protects against bone destructions in collagen induced arthritis by inhibiting osteoclastogenesis.柴胡皂苷 VI 通过抑制破骨细胞生成来防治胶原诱导性关节炎中的骨破坏。
Phytomedicine. 2019 Oct;63:153006. doi: 10.1016/j.phymed.2019.153006. Epub 2019 Jul 2.
4
Calcitonin-gene-related peptide stimulates stromal cell osteogenic differentiation and inhibits RANKL induced NF-kappaB activation, osteoclastogenesis and bone resorption.降钙素基因相关肽可刺激基质细胞成骨分化,并抑制 RANKL 诱导的 NF-κB 活化、破骨细胞生成和骨质吸收。
Bone. 2010 May;46(5):1369-79. doi: 10.1016/j.bone.2009.11.029. Epub 2009 Dec 2.
5
Obacunone inhibits RANKL/M-CSF-mediated osteoclastogenesis by suppressing integrin- FAK-Src signaling.奥巴库酮通过抑制整合素-FAK-Src信号传导来抑制RANKL/M-CSF介导的破骨细胞生成。
Cytokine. 2023 Apr;164:156134. doi: 10.1016/j.cyto.2023.156134. Epub 2023 Feb 15.
6
Caffeic acid 3,4-dihydroxy-phenethyl ester suppresses receptor activator of NF-κB ligand–induced osteoclastogenesis and prevents ovariectomy-induced bone loss through inhibition of mitogen-activated protein kinase/activator protein 1 and Ca2+–nuclear factor of activated T-cells cytoplasmic 1 signaling pathways.咖啡酸 3,4-二羟基苯乙基酯通过抑制丝裂原活化蛋白激酶/激活蛋白 1 和 Ca2+-活化 T 细胞胞浆 1 信号通路抑制核因子 κB 配体诱导的破骨细胞生成,预防卵巢切除诱导的骨丢失。
J Bone Miner Res. 2012 Jun;27(6):1298-1308. doi: 10.1002/jbmr.1576.
7
Piperlongumine, a -derived amide alkaloid, protects mice from ovariectomy-induced osteoporosis by inhibiting osteoclastogenesis suppression of p38 and JNK signaling.千里光碱,一种 - 衍生的酰胺生物碱,通过抑制破骨细胞生成和抑制 p38 和 JNK 信号通路来保护去卵巢诱导的骨质疏松症小鼠。
Food Funct. 2024 Feb 19;15(4):2154-2169. doi: 10.1039/d3fo03830k.
8
DOK3 Modulates Bone Remodeling by Negatively Regulating Osteoclastogenesis and Positively Regulating Osteoblastogenesis.DOK3 通过负向调节破骨细胞生成和正向调节成骨细胞生成来调节骨重塑。
J Bone Miner Res. 2017 Nov;32(11):2207-2218. doi: 10.1002/jbmr.3205. Epub 2017 Aug 2.
9
Sappanone A inhibits RANKL-induced osteoclastogenesis in BMMs and prevents inflammation-mediated bone loss.紫檀芪 A 抑制 BMMs 中 RANKL 诱导的破骨细胞生成,并防止炎症介导的骨质流失。
Int Immunopharmacol. 2017 Nov;52:230-237. doi: 10.1016/j.intimp.2017.09.018. Epub 2017 Sep 23.
10
Combination therapy with BMP-2 and a systemic RANKL inhibitor enhances bone healing in a mouse critical-sized femoral defect.BMP-2与全身性RANKL抑制剂联合治疗可促进小鼠临界尺寸股骨缺损的骨愈合。
Bone. 2016 Mar;84:93-103. doi: 10.1016/j.bone.2015.12.052. Epub 2015 Dec 23.

引用本文的文献

1
Targeting TYROBP to influence the immune microenvironment and osteogenic differentiation of mesenchymal stem cells.靶向TYROBP以影响间充质干细胞的免疫微环境和成骨分化。
J Orthop Surg Res. 2025 May 28;20(1):535. doi: 10.1186/s13018-025-05925-7.
2
Naringin promotes osteoblast differentiation and ameliorates osteoporosis in ovariectomized mice.柚皮苷促进去卵巢小鼠成骨细胞分化并改善骨质疏松症。
Sci Rep. 2025 Apr 12;15(1):12651. doi: 10.1038/s41598-025-97217-7.
3
[Molecular mechanism of magnesium alloy promoting macrophage M2 polarization through modulation of PI3K/AKT signaling pathway for tendon-bone healing in rotator cuff injury repair].

本文引用的文献

1
Enhancement and orchestration of osteogenesis and angiogenesis by a dual-modular design of growth factors delivery scaffolds and 26SCS decoration.通过生长因子递送支架的双模块设计和 26SCS 修饰增强和协调成骨和血管生成。
Biomaterials. 2020 Feb;232:119645. doi: 10.1016/j.biomaterials.2019.119645. Epub 2019 Dec 13.
2
Inequalities in prescription rates of anti-osteoporosis drugs in primary care in England: A practice-level prescribing data analysis in 2013-2018.英格兰初级保健中抗骨质疏松药物处方率的不平等:2013-2018 年基于实践层面的处方数据分析。
Bone. 2020 Jan;130:115125. doi: 10.1016/j.bone.2019.115125. Epub 2019 Nov 2.
3
[镁合金通过调节PI3K/AKT信号通路促进巨噬细胞M2极化在肩袖损伤修复中促进腱骨愈合的分子机制]
Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi. 2025 Feb 15;39(2):174-186. doi: 10.7507/1002-1892.202410010.
4
Biomaterial Cues for Regulation of Osteoclast Differentiation and Function in Bone Regeneration.用于调节骨再生中破骨细胞分化和功能的生物材料线索
Adv Ther (Weinh). 2025 Jan;8(1). doi: 10.1002/adtp.202400296. Epub 2024 Nov 15.
5
Biomaterial design for regenerating aged bone: materiobiological advances and paradigmatic shifts.用于老化骨再生的生物材料设计:材料生物学进展与范式转变
Natl Sci Rev. 2024 Feb 28;11(5):nwae076. doi: 10.1093/nsr/nwae076. eCollection 2024 May.
6
Enhancing the Biopharmacological Characteristics of Asperosaponin VI: Unveiling Dynamic Self-Assembly Phase Transitions in the Gastrointestinal Environment.增强天门冬总皂苷 VI 的生物药代动力学特性:揭示胃肠道环境中的动态自组装相转变。
Int J Nanomedicine. 2023 Dec 6;18:7335-7358. doi: 10.2147/IJN.S436372. eCollection 2023.
7
Unraveling the potential mechanisms of the anti-osteoporotic effects of the herb pair: a network pharmacology and experimental study.解析药对抗骨质疏松作用的潜在机制:一项网络药理学与实验研究
Front Pharmacol. 2023 Oct 2;14:1242194. doi: 10.3389/fphar.2023.1242194. eCollection 2023.
8
and Species-The Source of Specialized Metabolites with High Biological Relevance: A Review.以及 物种——具有高生物相关性的专业化代谢物的来源:综述。
Molecules. 2023 Apr 27;28(9):3754. doi: 10.3390/molecules28093754.
9
Kidney tonifying traditional Chinese medicine: Potential implications for the prevention and treatment of osteoporosis.补肾中药:对骨质疏松症防治的潜在意义
Front Pharmacol. 2023 Jan 9;13:1063899. doi: 10.3389/fphar.2022.1063899. eCollection 2022.
10
Circ_C4orf36 Promotes the Proliferation and Osteogenic Differentiation of BMSCs by Regulating VEGFA.环状 RNA_C4orf36 通过调节 VEGFA 促进 BMSCs 的增殖和成骨分化。
Biochem Genet. 2023 Jun;61(3):931-944. doi: 10.1007/s10528-022-10290-9. Epub 2022 Oct 15.
Manipulation of VEGF-induced angiogenesis by 2-N, 6-O-sulfated chitosan.
2-N, 6-O-磺酸化壳聚糖对 VEGF 诱导的血管生成的调控作用。
Acta Biomater. 2018 Apr 15;71:510-521. doi: 10.1016/j.actbio.2018.02.031. Epub 2018 Mar 12.
4
Mechanistic insight into contextual TGF-β signaling.深入了解上下文 TGF-β 信号转导的机制。
Curr Opin Cell Biol. 2018 Apr;51:1-7. doi: 10.1016/j.ceb.2017.10.001. Epub 2017 Nov 14.
5
"Bone Morphogenic Protein augmentation for long bone healing" response to "Clinical need for bone morphogenetic protein".“用于长骨愈合的骨形态发生蛋白增强”对“骨形态发生蛋白的临床需求”的回应
Int Orthop. 2017 Nov;41(11):2417-2419. doi: 10.1007/s00264-017-3595-y. Epub 2017 Sep 3.
6
2-N, 6-O-sulfated chitosan-assisted BMP-2 immobilization of PCL scaffolds for enhanced osteoinduction.2-N, 6-O-硫酸化壳聚糖辅助 BMP-2 固定于 PCL 支架以增强成骨诱导作用。
Mater Sci Eng C Mater Biol Appl. 2017 May 1;74:298-306. doi: 10.1016/j.msec.2016.12.004. Epub 2016 Dec 7.
7
Asperosaponin VI promotes bone marrow stromal cell osteogenic differentiation through the PI3K/AKT signaling pathway in an osteoporosis model.阿萨皂素 VI 通过骨质疏松症模型中的 PI3K/AKT 信号通路促进骨髓基质细胞成骨分化。
Sci Rep. 2016 Oct 19;6:35233. doi: 10.1038/srep35233.
8
Bone Mineral Density and Body Composition are Associated with Circulating Angiogenic Factors in Post-menopausal Women.骨矿物质密度和身体成分与绝经后女性循环血管生成因子相关。
Calcif Tissue Int. 2016 Dec;99(6):608-615. doi: 10.1007/s00223-016-0186-7. Epub 2016 Aug 30.
9
Enhanced osteogenesis of bone morphology protein-2 in 2-N,6-O-sulfated chitosan immobilized PLGA scaffolds.2-N,6-O-硫酸化壳聚糖固定化聚乳酸-羟基乙酸共聚物支架中骨形态发生蛋白-2的成骨增强作用
Colloids Surf B Biointerfaces. 2014 Oct 1;122:359-367. doi: 10.1016/j.colsurfb.2014.07.012. Epub 2014 Jul 18.
10
Vascularization and bone regeneration in a critical sized defect using 2-N,6-O-sulfated chitosan nanoparticles incorporating BMP-2.使用 2-N,6-O-硫酸化壳聚糖纳米粒包载 BMP-2 促进临界尺寸骨缺损中的血管化和骨再生。
Biomaterials. 2014 Jan;35(2):684-98. doi: 10.1016/j.biomaterials.2013.10.005. Epub 2013 Oct 18.